SOUTH WINDSOR, Conn., March 08, 2016 (GLOBE NEWSWIRE) -- Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, today announced that it has been named one of Fast Company’s Most Innovative Companies of 2016, an annual list honoring leading enterprises and rising newcomers that exemplify the best in nimble business and impactful innovation. OPM was selected as one of the Most Innovative Companies by sector in the biotech category for the Company’s first-in-kind SpineFab® VBR implant system, which received 510(k) clearance from the FDA in July of 2015.
“We are truly honored to be included on this prestigious list of innovation leaders,” said Severine Zygmont, President of OPM Biomedical. “Our product strategy is focused on a demanding healthcare environment that is undergoing rapid change. Through our OsteoFab® product lines, we strive to improve clinical outcomes while reducing overall costs – developing disruptive solutions that will enjoy burgeoning demand across the globe. Our plan is to meet those unmet needs through advanced materials science, innovative product design, and smart distribution.”
A pioneer in personalized medicine, OPM Biomedical became the only company to receive FDA clearance to manufacture 3D printed patient‐specific polymeric implants when it received 510(k) clearance in February, 2013 for its cranial prostheses line for surgeons around the world in February 2013*. The Company now has two additional FDA clearances, and is an original equipment manufacturer (OEM) for maxillofacial implants as well as its first spinal implant line. (*OPM Biomedical has now shipped over 900 cranial implants.)
Zimmer Biomet is exclusive worldwide distributor of OPM’s cranial and maxillofacial implants, and on February 17, 2016 OPM and RTI Surgical®, a leading global surgical implant company, announced that RTI Surgical has been granted an exclusive license to OPM’s OsteoFab technology platform for spinal applications in all U.S. markets. OPM also provides contract manufacturing services to third parties for a broad range of 3D printed biomedical implant applications.
Most Innovative Companies is one of Fast Company's most significant and highly anticipated editorial efforts of the year. To produce the 2016 list, the magazine's editors spent a full year gathering and analyzing data on companies around the globe. For the first time, Fast Company enlisted machine intelligence to help inform the list: Quid, a San Francisco-based startup, used its software to create topographical maps of innovation across more than 40 sectors of the economy. "This year's package—which includes top ten lists in 27 sectors—emphasizes the breadth of companies with progressive, agile business models, cultures of creativity, and ability to adapt in today's fast-paced world," said Fast Company editor Robert Safian.
Fast Company's Most Innovative Companies issue (March 2016) is now available online at http://www.fastcompany.com/most-innovative-companies as well as in app form via iTunes, and on newsstands.
About Fast Company
Fast Company is the world's leading progressive business media brand, with a unique editorial focus on innovation in technology, ethical economics, leadership, and design. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, one of the U.S.'s leading media companies.
About Oxford Performance Materials, Inc.
Oxford Performance Materials Inc. (OPM) is a recognized leader in advanced materials science and has developed a range of 3D printing and high performance additive manufacturing (HPAM™) technologies that deliver fully functional end-use products to the biomedical, aerospace, and industrial markets. Founded in 2000, the Company’s focus has been on high performance polymers, and OPM has developed a range of unique, enterprise-level additive manufacturing solutions utilizing its proprietary OXPEKK® polymer formulations and additive manufacturing processes.
A pioneer in personalized medicine, OPM Biomedical became the first and only company to receive 510(k) clearance from the FDA to manufacture 3D printed patient-specific polymeric implants, initially for its cranial prostheses line in February 2013. Additional FDA clearances for OPM Biomedical’s OsteoFab® technology followed for OPM’s patient-specific facial implant line and its SpineFab® VBR system, which provides the first and only FDA cleared 3D printed load-bearing polymeric medical device in the market.
OPM's Aerospace & Industrial group delivers 3D printed OXFAB® production parts for a range of highly demanding aerospace and defense applications. OXFAB structures offer significant weight and cost reduction, combined with a set of specific performance attributes verified in the exhaustive OPM B-Basis database, developed in conjunction with NASA.
For more information, please visit: http://www.oxfordpm.com/